Endocrinology (all articles)
RCT | Efficacy of a commercial weight management program compared with a do-it-yourself approach.
27 Sep, 2022 | 13:05h | UTCCommentary: Weight Loss Greater With Commercial Weight Management Program – HealthDay
Commentary on Twitter
In this RCT, a commercial weight management program resulted in more weight reduction than a do-it-yourself approach at 3 months and 1 year. https://t.co/N8HAr7uw3p pic.twitter.com/UbvA1i8Kam
— JAMA Network Open (@JAMANetworkOpen) August 16, 2022
ADA/EASD Consensus Report | Management of Hyperglycemia in Type 2 Diabetes, 2022.
26 Sep, 2022 | 12:11h | UTCCommentary: ADA/EASD hyperglycemia management consensus update strengthens holistic care – medwire News
M-A | Association of gestational diabetes mellitus with cardiovascular and cerebrovascular diseases.
26 Sep, 2022 | 12:01h | UTCNews Release: Diabetes in pregnancy linked to risk of cardiovascular and cerebrovascular disease – BMJ Newsroom
Commentary on Twitter
Gestational diabetes mellitus is associated with increased risks of overall and type specific cardiovascular and cerebrovascular diseases that cannot be solely attributed to conventional cardiovascular risk factors or subsequent diabetes, finds new studyhttps://t.co/0fCIXKVK99
— The BMJ (@bmj_latest) September 22, 2022
Cohort Study | Modifiable risk factors may reduce the risk of type 2 diabetes in patients with a history of gestational diabetes.
23 Sep, 2022 | 13:08h | UTCNews Release: Healthy lifestyle linked to 90% lower risk of diabetes in susceptible women – BMJ Newsroom
Commentary on Twitter
Women with a history of diabetes in pregnancy can still reduce their chances of developing type 2 diabetes by adopting a healthy lifestyle, such as eating healthy, stopping smoking, exercising regularly, and not being overweight, finds new studyhttps://t.co/UkArl7ZyBS
— The BMJ (@bmj_latest) September 22, 2022
RCT | Insulin Glargine vs. Glimepiride vs. Sitagliptin vs. Liraglutide resulted in similar microvascular outcomes and death rates in patients with Type 2 diabetes not controlled with metformin.
22 Sep, 2022 | 13:20h | UTCGlycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Related Study: Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes – New England Journal of Medicine
News Release: Two popular diabetes drugs outperformed others in large clinical trial – National Institutes of Health
Study shows that the leading causes of hospitalization of adults with diabetes are changing.
22 Sep, 2022 | 13:08h | UTCCommentaries:
The changing character of diabetes complications – The Lancet Diabetes & Endocrinology (free registration required)
Reasons for hospital admissions in people with type 2 diabetes are changing – MedicalXpress
Review | Adrenal insufficiency in cirrhosis.
22 Sep, 2022 | 12:59h | UTCAdrenal Insufficiency in Cirrhosis – Journal of the Endocrine Society
RCT | Effects of an exercise program on brain health outcomes for children with overweight or obesity.
21 Sep, 2022 | 13:17h | UTCNews Release: Study finds schoolchildren who exercise perform better academically – University of Granada
Commentary: Exercise Improves Brain Health in Overweight, Obese Youth – HealthDay
Commentary on Twitter
Intelligence, cognitive flexibility and academic performance improved following a 20-week RCT based on aerobic + resistance training among children with overweight or obesity. @ortegaporcel @profithugr @canalUGR and collaborators. #OpenAccess #Research https://t.co/XYddOoO7e7 pic.twitter.com/rZpjJxe3tr
— JAMA Network Open (@JAMANetworkOpen) August 30, 2022
Network M-A | Associations between statins and adverse events in secondary prevention of cardiovascular disease.
20 Sep, 2022 | 13:30h | UTC
RCT | Open-source automated insulin delivery in Type 1 Diabetes.
19 Sep, 2022 | 12:41h | UTCOpen-Source Automated Insulin Delivery in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Video summary: Open-Source Automated Insulin Delivery in Type 1 Diabetes – NEJM
Commentaries:
Automated Insulin Delivery Ups Time in Target Glucose Range in T1D – HealthDay
Cohort Study | Patients diagnosed with diabetes by oral glucose tolerance test without elevated HbA1c had similar cardiovascular and renal disease risks as those without diabetes.
15 Sep, 2022 | 13:12h | UTC
Commentary on Twitter
#OriginalResearch: Oral glucose tolerance test diagnosed #diabetes were not confirmed by HbA1c during 4 year follow-up. Cases without HbA1c confirmation had similar vascular risk as the diabetes-free population. @whitehall2study @MikaKivimaki #AHAJournals https://t.co/ujC8cjRS7S pic.twitter.com/CRR3zlm5x2
— Circulation (@CircAHA) August 30, 2022
Consensus recommendations for the use of Automated Insulin Delivery (AID) technologies in clinical practice.
15 Sep, 2022 | 13:06h | UTC
Cohort Study | A 7-year study of the durability of improvements in pain, physical function, and work productivity after Roux-en-Y gastric bypass and sleeve gastrectomy.
15 Sep, 2022 | 13:03h | UTCNews Release: Beyond weight loss: Improvements in pain, mobility persist long after bariatric surgery – University of Pittsburgh
Author Interview: Long-term Changes in Pain, Physical Function, and Work Productivity After Bariatric Surgery – JAMA
USPSTF Statement | The current evidence is insufficient to recommend routine screening for prediabetes and type 2 diabetes in children and adolescents.
14 Sep, 2022 | 13:23h | UTCEditorials:
Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes – JAMA
Broader Screening for Youth-Onset Type 2 Diabetes—We Just Are Not There Yet – JAMA Network Open
Patient Page: Screening for Type 2 Diabetes in Children and Adolescents – JAMA
Author Interview: USPSTF Recommendation: Screening for Prediabetes and Diabetes in Children and Adolescents – JAMA
Expert Opinion | Clinical management of pregnancy in women with polycystic ovary syndrome.
14 Sep, 2022 | 13:02h | UTC
Cluster RCT | Tighter vs. less tight glycemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity.
13 Sep, 2022 | 13:21h | UTC
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study.
13 Sep, 2022 | 13:02h | UTCRelated study: Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing’s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
RCT | In youths with new-onset type 1 diabetes, intensive glucose control for 24 months with a closed-loop system did not help to preserve pancreatic function.
11 Sep, 2022 | 22:57h | UTCClosed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
Preservation of C-Peptide Secretion Examined in Youth With T1D – HealthDay
Commentary on Twitter (video summary)
In patients with newly diagnosed type 1 diabetes, it is uncertain whether intensive glucose control can prevent the decline in endogenous insulin secretion. New research findings are summarized in a short video. https://t.co/gJeYus4G5z pic.twitter.com/igclSnyanu
— NEJM (@NEJM) September 10, 2022
Cohort study showed a possible link between artificial sweeteners and heart disease.
11 Sep, 2022 | 22:55h | UTCNews Release: Possible link between artificial sweeteners and heart disease – BMJ Newsroom
Original Study: Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort – The BMJ
A randomized crossover trial with 12 patients showed that a bihormonal “artificial pancreas” with closed-loop glucose control increases patients’ time on euglycemia after total pancreatectomy.
11 Sep, 2022 | 22:45h | UTCBihormonal Artificial Pancreas With Closed-Loop Glucose Control vs Current Diabetes Care After Total Pancreatectomy: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary: Novel Bihormonal Artificial Pancreas Beneficial After Pancreatectomy – HealthDay
Network M-A | Comparative efficacy of lipid‐lowering therapies added to maximally tolerated statins for the reduction of LDL cholesterol.
11 Sep, 2022 | 22:38h | UTC
Systematic Review | Surgery for the treatment of obesity in children and adolescents.
11 Sep, 2022 | 22:29h | UTCSurgery for the treatment of obesity in children and adolescents – Cochrane Library
Summary: Surgery for the treatment of obesity in children and adolescents – Cochrane Library
Study shows bariatric surgery is more effective than lifestyle for type 2 diabetes remission.
8 Sep, 2022 | 14:27h | UTCNews Release: Bariatric surgery more effective than lifestyle for type 2 diabetes remission – Pennington Biomedical Research Center
Original Study: Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) – Diabetes Care
M-A | Hypocalcemia following thyroidectomy among patients who have previously undergone bariatric surgery.
8 Sep, 2022 | 14:25h | UTCHypocalcaemia following thyroidectomy among patients who have previously undergone bariatric surgery: systematic review and meta-analysis – British Journal of Surgery (link to abstract – $ for full-text)
RCT | Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes.
7 Sep, 2022 | 12:30h | UTCAdvanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study – The Lancet Endocrinology (link to abstract – $ for full-text)
Commentary: ‘Artificial Pancreas’ Best in Poorly Controlled Type 1 Diabetes – Medscape (free registration required)
Commentary on Twitter
New—Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 #diabetes (ADAPT): a randomised controlled study https://t.co/XrrmoDuQLy #T1D pic.twitter.com/GSLWA3xX7F
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) September 2, 2022